Ghanbar Mahmoodi Chalbatani

About Ghanbar Mahmoodi Chalbatani

Ghanbar Mahmoodi Chalbatani, With an exceptional h-index of 13 and a recent h-index of 13 (since 2020), a distinguished researcher at Tehran University of Medical Sciences, specializes in the field of Tumor immunology, Cancer therapy, CAR T cell therapy, Cancer genomics, Autoimmune disease.

His recent articles reflect a diverse array of research interests and contributions to the field:

Evolution of cell therapy for renal cell carcinoma

Isolated Peptide from Spider Venom Modulates Dendritic Cells In Vitro: A Possible Application in Oncoimmunotherapy for Glioblastoma

Dual blockage of both PD-L1 and CD47 enhances the therapeutic effect of oxaliplatin and FOLFOX in CT-26 mice tumor model

CD171 Multi-epitope peptide design based on immuno-informatics approach as a cancer vaccine candidate for glioblastoma

Functional characterization and development of novel human kinase insert domain receptor chimeric antigen receptor T-cells for immunotherapy of non-small cell lung cancer

The integrative multi-omics approach identifies the novel competing endogenous RNA (ceRNA) network in colorectal cancer

Co-expression of PD-1 with TIGIT or PD-1 with TIM-3 on tumor-infiltrating CD8+ T cells showed synergistic effects on improved disease-free survival in treatment-naïve CRC patients

Radiation dose and schedule influence the abscopal effect in a bilateral murine CT26 tumor model

Ghanbar Mahmoodi Chalbatani Information

University

Position

Research Assistant Department of Immunology School of Medicine

Citations(all)

1312

Citations(since 2020)

1278

Cited By

292

hIndex(all)

13

hIndex(since 2020)

13

i10Index(all)

15

i10Index(since 2020)

14

Email

University Profile Page

Tehran University of Medical Sciences

Google Scholar

View Google Scholar Profile

Ghanbar Mahmoodi Chalbatani Skills & Research Interests

Tumor immunology

Cancer therapy

CAR T cell therapy

Cancer genomics

Autoimmune disease

Top articles of Ghanbar Mahmoodi Chalbatani

Title

Journal

Author(s)

Publication Date

Evolution of cell therapy for renal cell carcinoma

Yufei Wang

Eloah Rabello Suarez

Gabriella Kastrunes

Najla Santos Pacheco de Campos

Rabia Abbas

...

2024/12

Isolated Peptide from Spider Venom Modulates Dendritic Cells In Vitro: A Possible Application in Oncoimmunotherapy for Glioblastoma

Cells

Felipe Cezar de Mato

Natália Barreto

Gabriel Cordeiro

Jaqueline Munhoz

Amanda Pires Bonfanti

...

2023/3/27

Dual blockage of both PD-L1 and CD47 enhances the therapeutic effect of oxaliplatin and FOLFOX in CT-26 mice tumor model

Scientific Reports

Reza Alimohammadi

Ghanbar Mahmoodi Chalbatani

Masoumeh Alimohammadi

Haniyeh Ghaffari-Nazari

Arezou Rahimi

...

2023/2/11

CD171 Multi-epitope peptide design based on immuno-informatics approach as a cancer vaccine candidate for glioblastoma

Journal of Biomolecular Structure and Dynamics

Seyed Amir Hossein Mohammadzadeh Hosseini Moghri

Ghanbar Mahmoodi Chalbatani

Mojtaba Ranjbar

Catarina Raposo

Arefeh Abbasian

2023/2/11

Functional characterization and development of novel human kinase insert domain receptor chimeric antigen receptor T-cells for immunotherapy of non-small cell lung cancer

European Journal of Pharmaceutical Sciences

Ming Zhong

Ghanbar Mahmoodi Chalbatani

Meifang Deng

Qiuyi Li

Elahe Gharagouzloo

...

2023/1/1

The integrative multi-omics approach identifies the novel competing endogenous RNA (ceRNA) network in colorectal cancer

Scientific Reports

Ghanbar Mahmoodi Chalbatani

Elahe Gharagouzloo

Mohammad Amin Malekraeisi

Paniz Azizi

Amirabbas Ebrahimi

...

2023/11/9

Co-expression of PD-1 with TIGIT or PD-1 with TIM-3 on tumor-infiltrating CD8+ T cells showed synergistic effects on improved disease-free survival in treatment-naïve CRC patients

International Immunopharmacology

Abdo Meyiah

Ghanbar Mahmoodi Chalbatani

Mohamed A Al-Mterin

Mohammad Amin Malekraeisi

Khaled Murshed

...

2023/6/1

Radiation dose and schedule influence the abscopal effect in a bilateral murine CT26 tumor model

International immunopharmacology

Haniyeh Ghaffari-Nazari

Masoumeh Alimohammadi

Reza Alimohammadi

Elham Rostami

Mohsen Bakhshandeh

...

2022/7/1

Carbonic anhydrase IX: A renewed target for cancer immunotherapy

Najla Santos Pacheco de Campos

Bruna Santos Souza

Giselle Correia Próspero da Silva

Victoria Alves Porto

Ghanbar Mahmoodi Chalbatani

...

2022/3/9

Combining ablative radiotherapy and anti CD47 monoclonal antibody improves infiltration of immune cells in tumor microenvironments

PLoS One

Elham Rostami

Mohsen Bakhshandeh

Haniyeh Ghaffari-Nazari

Maedeh Alinezhad

Masoumeh Alimohammadi

...

2022/8/26

CAR-T cells: Early successes in blood cancer and challenges in solid tumors

Hassan Dana

Ghanbar Mahmoodi Chalbatani

Seyed Amir Jalali

Hamid Reza Mirzaei

Stephan A Grupp

...

2021/5/1

Neuroblastoma‐targeted nanoparticles and novel nanotechnology‐based treatment methods

Taranom Mobasheri

Elham Rayzan

Mahsima Shabani

Mina Hosseini

Ghanbar Mahmoodi Chalbatani

...

2021/3

Integrative and in-vitro analysis reveal hsa_circ_001787 can act as a diagnostic biomarker for colorectal cancer

Saudi Journal of Biological Sciences

Ghanbar Mahmoodi Chalbatani

Elahe Gharagouzloo

Fereidoon Memari

Hassan Dana

Mohammad Hosein Mohammadi Hadloo

...

2021/11/1

The hippo tumor suppressor pathway (yap/taz/tead/mst/lats) and egfr-ras-raf-mek in cancer metastasis

Mohammad Reza Zinatizadeh

Seyed Rouhollah Miri

Peyman Kheirandish Zarandi

Ghanbar Mahmoodi Chalbatani

Catarina Rapôso

...

2021/1/1

Components from spider venom activate macrophages against glioblastoma cells: new potential adjuvants for anticancer immunotherapy

The journal of biochemistry

Jaqueline Munhoz

Gabriela Peron

Amanda Pires Bonfanti

Janine Oliveira

Thomaz AA da Rocha‐e‐Silva

...

2021/7/1

Chimeric antigen receptor (CAR) T cell therapy for metastatic melanoma: challenges and road ahead

Tahereh Soltantoyeh

Behnia Akbari

Amirali Karimi

Ghanbar Mahmoodi Chalbatani

Navid Ghahri-Saremi

...

2021/6/9

The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases

Mohammad Reza Zinatizadeh

Bettina Schock

Ghanbar Mahmoodi Chalbatani

Peyman Kheirandish Zarandi

Seyed Amir Jalali

...

2021/5/1

A new world of biomarkers and therapeutics for female reproductive system and breast cancers: circular RNAs

Anh M Tran

Ghanbar Mahmoodi Chalbatani

Lea Berland

Mireia Cruz De los Santos

Priyank Raj

...

2020/3/9

In silico analysis, molecular docking, molecular dynamic, cloning, expression and purification of chimeric protein in colorectal cancer treatment

Drug design, development and therapy

Hassan Dana

Ghanbar Mahmoodi Chalbatani

Elahe Gharagouzloo

Seyed Rouhollah Miri

Fereidoon Memari

...

2020/1/23

Molecular docking of the pneumococcal main autolysin (LytA) and deoxycholate ligand

Pakistan Journal of Pharmaceutical Sciences

Ghanbar Mahmoodi Chalbatani

Samira Karimaei

Davoud Afshar

Solmaz Ohadian Moghadam

Habibollah Mahmoodzadeh

...

2020/9/1

See List of Professors in Ghanbar Mahmoodi Chalbatani University(Tehran University of Medical Sciences)

Co-Authors

H-index: 98
Stephan A. Grupp

Stephan A. Grupp

University of Pennsylvania

H-index: 67
Wayne A. Marasco

Wayne A. Marasco

Harvard University

H-index: 22
Seyed Amir Jalali

Seyed Amir Jalali

Shahid Beheshti University of Medical Sciences

H-index: 10
Eloah Rabello Suarez

Eloah Rabello Suarez

Universidade Federal do ABC

academic-engine